Hina Singh | Neuroscience | Best Researcher Award

Published on by Best Achievements

Dr. Hina Singh | Neuroscience | Best Researcher Award 

University of California, Riverside | United States

Dr. Hina Singh, Ph.D., currently serves as an Assistant Project Scientist in the Division of Biomedical Sciences at the School of Medicine, University of California, Riverside, USA. Her research focuses on neuroHIV, neuroimmunology, and nanobiotechnology, with particular expertise in investigating the role of interferon signaling in HIV-associated neurocognitive disorders and methamphetamine-induced neurotoxicity. She possesses extensive experience in neuronal and microglial cell culture, molecular biology, and advanced microscopy techniques, alongside proficiency in nanoparticle synthesis and biosensor development. Dr. Singh’s scholarly contributions are reflected in 55 peer-reviewed publications, accumulating over 2,190 citations and an impressive h-index of 23, highlighting her significant impact in biomedical and nanoscience research. Her scientific journey spans diverse areas, including superparamagnetic iron oxide nanoparticles, gold nanoparticle-based biosensors, and the synthesis of biocompatible nanomaterials for therapeutic applications. She has also been actively involved in mentoring students and collaborating on interdisciplinary research projects bridging neurobiology and nanotechnology. A recipient of multiple international honors such as the Early Career Investigator Travel Award and President’s Scholarship, Dr. Singh continues to advance translational research aimed at understanding molecular mechanisms underlying neuroinflammation, viral neuropathogenesis, and neuroprotective therapeutic strategies.

Profile: Scopus | Orcid 

Featured Publications 

Singh, H., et al. (2025). Medical importance and pharmacokinetics of gold nanoparticles in the human body. Molecular Cancer.

Singh, H., et al. (2025). EphB2-mediated ephrin-B reverse signaling on microglia drives an anti-viral, but inflammatory and neurotoxic response associated with HIV. Journal of Neuroinflammation.

Singh, H., et al. (2025). Advanced nanomaterials for cancer therapy: Gold, silver, and iron oxide nanoparticles in oncological applications.

Singh, H., et al. (2025). Advances in precision oncology using patient-derived organoids and functional biomaterials.

Singh, H., et al. (2024). Interferon-β deficiency alters brain response to chronic HIV-1 envelope protein exposure in a transgenic model of NeuroHIV. Brain, Behavior, and Immunity.

Falguni Goel | Neuropharmacology | Women Researcher Award

Published on by Best Achievements

Ms Falguni Goel | Neuropharmacology | Women Researcher Award

Ms. Falguni Goel, MIET, India.

🔬 Ms. Falguni Goel is a dedicated researcher and Assistant Professor at MIET, Meerut, specializing in neuropharmacology and molecular biotechnology. With a passion for understanding neuropsychiatric disorders like Huntington’s and Parkinson’s, she brings innovation through herbal drug discovery and advanced lab techniques. 🧠 She holds multiple patents, has published in high-impact journals 📚, and excels in zebrafish-based research. 🎯 Falguni’s goal is to blend science, creativity, and compassion to make breakthroughs in neurotherapeutics. 💡

Profile

Scopus Profile

Orcid profile

Google Scholar Profile

🎓 Early Academic Pursuits

Falguni Goel, has demonstrated exceptional commitment to science from an early age. Her academic journey began with a passion for biology and evolved into a specialized interest in neuropharmacology and molecular biotechnology. With a solid foundation laid during her M.Pharm studies, she completed a compelling thesis titled “Protective Effect of Diacerein in Quinolinic Acid Induced Huntington’s Like Symptoms in Adult Zebrafish Targeting GSK-3β Signalling”, showcasing her early focus on neurodegenerative research. 🧬📘

💼 Professional Endeavors

Currently serving as an Assistant Professor at MIET, Meerut, Falguni blends academic leadership with active research. She is also an enthusiastic educator and mentor, committed to shaping the next generation of pharmaceutical and neuroscience researchers. Her drive for innovation is deeply tied to her academic and professional goals. 🎓📚

🔬 Contributions and Research Focus On Neuropharmacology 

Falguni’s research is sharply focused on neuropsychiatric disorders, particularly Huntington’s, Parkinson’s, Dementia, Autism, and depression. She explores molecular pathways, diagnostic markers, and behavioral models in zebrafish and rodents to understand these conditions. Her work emphasizes drug development using both synthetic and herbal phytochemicals, aiming to bridge traditional and modern approaches in neuroscience. 🧪🧠🌿

🌍 Impact and Influence

Her impactful research is evident in numerous high-impact publications and national patents. Her findings have not only advanced understanding of neurological disorders but also introduced new experimental methodologies and apparatus for behavioral studies. She has set benchmarks, particularly in zebrafish brain studies and drug delivery techniques. 🏅💡

🧠 Research Skills

Falguni is skilled in a wide array of research techniques:

  • Zebrafish and rodent behavioral modeling 🐟🐀

  • Brain dissection, histopathology, and drug delivery via multiple routes 🧠💉

  • Molecular techniques including Western Blot, PCR, ELISA, HPLC, and cryo-sectioning 🧫🔬

  • Biochemical analysis of neurotransmitters and signaling proteins 🧬🧪

  • Expertise in behavioral software (AnyMaze), data analysis tools (GraphPad Prism), and manuscript writing 📊📝

She is known for pioneering i.c.v. administration in zebrafish in India and innovating several research apparatuses enhancing experimental reliability.

🏅 Awards and Honors

Falguni’s scholarly achievements have earned her numerous accolades, including multiple granted patents by the Government of India. Her innovations in experimental neuroscience are widely recognized, including devices such as the Zebrafish Behavioral Exploration Apparatus and Electro-convulsiometer Ring for Rodents. Her early participation in the national platform Pariksha pe Charcha with Prime Minister Modi also reflects her active civic engagement. 🥇📜

🏛️ Legacy and Future Contributions

With over a dozen patents and 20+ publications already under her name at just 23, Falguni Goel’s legacy is only beginning. She envisions pioneering more AI-integrated health solutions and developing innovative tools to advance neuropharmacology. Her dedication promises substantial contributions to neuroscience, both academically and clinically, in the coming decades. 🚀🧠🧑‍🔬

Publications Top Notes

📄 Apigenin protects melanocytes and improve tyrosinase activity in a hydroquinone induced vitiligo mouse model targeting P38 MAP kinase signaling: histopathology and …
📚 Naunyn-Schmiedeberg’s Archives of Pharmacology
🗓️ 2024

🧠 Protective effects of diacerein against quinolinic acid–induced Huntington’s disease–like symptoms in adult zebrafish by targeting GSK-3β signalling
📚 Naunyn-Schmiedeberg’s Archives of Pharmacology
🗓️ 2025

🧬 Beyond dopamine: novel therapeutic pathways for Parkinson’s disease through receptor signaling
📚 CNS & Neurological Disorders – Drug Targets
🗓️ 2025

🧩 From Genetics to Function: the Role of ABCA12 in Autism Neurobiology
📚 Journal of Molecular Neuroscience
🗓️ 2025

🤖 The Future of Drug Development: Leveraging AI for Faster and Safer Innovation
📚 Journal of Advanced Scientific Research
🗓️ 2025